HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

The European Commission says it plans to clear up some of the uncertainties about the animal testing ban when the ban goes into effect March 11. Market researcher Packaged Facts says oral-care product sales in the US grew to near $5 billion annually.

You may also be interested in...



Questions Remain On Animal Testing Ban, Possible Loopholes

While it appears inevitable that the European Commission’s full ban on testing cosmetic ingredients on animals will proceed starting March 11 as dictated by the Cosmetics Directive, how the EC and member states will interpret and enforce the ban remains to be seen. Consulting firm Technology Sciences Group believes the regulation may be more flexible, and less onerous, than anticipated.

Henlius Has Denosumab Application Accepted In China

Shanghai Henlius Biotech has announced that China’s NMPA has accepted the firm’s filing for its HLX14 denosumab biosimilar. Meanwhile, the company has also announced dosing the first patient in a Phase II clinical trial of its novel HLX10 anti-PD-1 monoclonal antibody.

Global AMR R&D Hub launches Dynamic Data Dashboard

The Global AMR R&D Hub’s newly launched Dynamic Dashboard aims to be “a comprehensive knowledge center for AMR R&D and market reforms,” its head tells Scrip.

Topics

Related Companies

UsernamePublicRestriction

Register

RS018922

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel